Telix Pharmaceuticals Limited American Depositary Shares (TLX) is a publicly traded Healthcare sector company. As of May 21, 2026, TLX trades at $10.28 with a market cap of $3.48B and a P/E ratio of 0.00. TLX moved +0.93% today. Year to date, TLX is +35.62%; over the trailing twelve months it is -37.32%. Its 52-week range spans $6.28 to $30.36. Analyst consensus is buy with an average price target of $17.00. Rallies surfaces TLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Telix Pharmaceuticals Limited American Depositary Shares (TLX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TLX moved +0.93% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $10.28 |
| Market Cap | $3.48B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.04% |
| 52-Week High | $30.36 |
| 52-Week Low | $6.28 |
| Volume | 93.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover TLX: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.00.